Risiko
Bærekraft
(1 av 3)
🌳
🌳
🌳
Totalpris (det du betaler årlig):
1,43%
Prisdetaljer
Pris for fondet:
1,93%
Plattformavgift:
0,25%
Returprovisjon:
-0,75%
Vis priser med rabatt for Akademikerne Pluss eller Tekna
Avkastning pr. 25.04
Siste måned:
0,1%
Siste 6 måneder:
12,0%
Hittil i år:
14,5%
Siste år:
8,9%
Siste 3 år (per år):
9,7%
Siste 5 år (per år):
12,6%
Morningstar-rating:
3
ISIN:
LU1775982595
Forvaltningskapital:
3 240 621 708 kr
Kategori:
Bransjefond, Helsevern
NAV/Kurs (25.04.2024):
2 087 kr
Obligasjoner:
0,0%
Kontanter:
0,1%
Aksjer:
98,8%
Annet:
1,1%
Startdato:
07.09.2018
10 største eierandeler
UnitedHealth Group Inc
8,4%
Eli Lilly and Co
7,9%
Vertex Pharmaceuticals Inc
4,5%
Boston Scientific Corp
4,5%
McKesson Corp
3,7%
Regeneron Pharmaceuticals Inc
3,3%
Zoetis Inc Class A
3,3%
Stryker Corp
3,1%
Merck & Co Inc
3,0%
AstraZeneca PLC ADR
3,0%
Helse
99,6%
Eiendom
0,4%
Nord-Amerika
92,3%
Europa
7,6%
Asia
0,2%
The Fund aims to achieve long-term capital growth. The Fund seeks to achieve its objective by investing primarily in equity and equity related securities of innovative healthcare companies throughout the world. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Investment Manager seeks to invest in companies that have the potential to materially improve the quality of care, access to care or cost of care through their innovative approach to products and services, use of technology, processes and business models, or management.